Related Experiment Video
Updated: Jun 4, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
Published on: December 10, 2012
NExON-Bayes: A Bayesian approach to network estimation informed by ordinal covariates.
Joseph Feest1, Hélène Ruffieux1, Camilla Lingjærde2
1MRC Biostatistics Unit, University of Cambridge, East Forvie Site, CB2 0SR, Cambridge, UK.
This study introduces NExON-Bayes, a novel method for analyzing omic networks in heterogeneous diseases. It improves network estimation accuracy by incorporating disease stage, offering better insights into biological pathway shifts.
Area of Science:
- Computational Biology
- Bioinformatics
- Statistical Genetics
Background:
- Omic network analysis is vital for understanding complex diseases.
- Existing methods often assume data homogeneity, leading to inaccurate network estimates.
- Accounting for sample variability, such as disease stage, is crucial for reliable omic network analysis.
Purpose of the Study:
- To develop a joint Gaussian graphical model that accounts for sample-level ordinal covariates to improve omic network estimation.
- To address the challenge of heterogeneity in disease settings for more interpretable omic network estimates.
- To provide a robust framework for analyzing dynamic biological networks across disease progression.
Main Methods:
- Proposed NExON-Bayes, an extension of the graphical spike-and-slab framework incorporating ordinal covariates.
- Developed an efficient variational inference algorithm for high-dimensional omic data.
- Validated the method through simulations and application to breast carcinoma proteomic data.
Main Results:
- NExON-Bayes demonstrated superior performance compared to existing network approaches in simulations.
- The method accurately estimated proteomic network structures and covariate dependencies in breast cancer.
- Identified shifts in biological pathways across different stages of breast carcinoma progression.
Conclusions:
- NExON-Bayes effectively models heterogeneity in omic data using ordinal covariates.
- The framework provides comprehensive insights into dynamic biological networks and disease progression.
- The developed R package facilitates the application of this advanced network analysis technique.
Related Concept Videos
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Friedman Two-way Analysis of Variance by Ranks
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Distributions to Estimate Population Parameter
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
The...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...